**Clayface's** $3.5 million Thursday previews and current presale data anchor trader consensus around a sub-$25 million domestic opening, with the bulk of implied probability clustered below $22 million or in the $22–25 million range. The R-rated body-horror entry from DC Studios carries a modest $40–44 million production budget and faces immediate competition from A24's buzzy Elizabeth Holmes documentary *You Can See Everything*, which is expanding widely after a strong debut. Tracking services show estimates spanning roughly $20–30 million, tempered by limited overall awareness despite solid audience scores and favorable early reviews. The lower-budget genre positioning and Halloween-adjacent timing support a profitable outcome even at the conservative end of forecasts, though the documentary's momentum remains the key swing factor for final figures.